Form 4 for TSLA Tesla, Inc.
Accepted 2026-05-15 19:33:47 ET · period of report 2026-05-13 · accession 0001104659-26-062860 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-15 19:33 | 2026-05-13 | TSLA | Taneja Vaibhav | CFO | M - OptEx | $18.29 | +3,000 | 21.1K | +17% | +$54.9K |
| D | 2026-05-15 19:33 | 2026-05-13 | TSLA | Taneja Vaibhav | CFO | S - Sale+OE | $450.00 | -3,000 | 18.1K | -14% | -$1.35M |
| DM | 2026-05-15 19:33 | 2026-05-13 | TSLA | Taneja Vaibhav | CFO | M - OptEx | $0.00 | -3,000 | 711.9K | -0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-13 | M | A | 1,000 | $18.44 | 19,106.50 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. |
| 2 | Common | Common Stock | 2026-05-13 | M | A | 2,000 | $18.22 | 21,106.50 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. |
| 3 | Common | Common Stock | 2026-05-13 | S | D | 3,000 | $450.00 | 18,106.50 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. (F2) Out of the total of 3,000 shares sold on May 13, 2026, approximately 1,337 shares were sold to cover the exercise price, and to satisfy the reporting person's tax withholding obligations related to the exercise of stock options to purchase 3,000 shares as reported herein. |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-05-13 | M | D | 1,000 | $0.00 | 2,390 | D | $18.44 · — to 2028-10-16 | 1,000 Common Stock | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. (F4) Represents part of a single option award grant, including Incentive Stock Options. 1/60th of the aggregate shares subject to the option became vested and exercisable on November 1, 2018, and 1/60th of the shares subject to the option shall become vested and exercisable each month thereafter, so that all such shares subject to this option became fully vested on October 1, 2023. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-05-13 | M | D | 2,000 | $0.00 | 711,920 | D | $18.22 · — to 2029-04-19 | 2,000 Common Stock | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. (F5) 1/8th of the shares subject to the option became vested and exercisable on September 13, 2019, and an additional 1/48th of the shares subject to the option vested each month thereafter, so that all such shares subject to this option became fully vested on March 13, 2023. |